top of page
balls_magenta.png

New type of plaftorm-based biotech company

ABOUT SAPIENTIS

We aspire to enable Biopharma companies to exceed their goals in developing and delivering lifetransforming nucleic-acid therapies, production processes, as well as GMP manufacturing of biopharmaceutical drug substances.


We are establishing a premier ecosystem to enable network effects, scientific progress, and shared learnings to speed up the availability of biotechnological solutions for serious diseases within infectious diseases, onco-immunology, and precision medicine in rare diseases, concentrating on pilot projects and delivering products for clinical trial activities.

 

We will provide comprehensive GMP development and the complete spectrum of services from discovery to drug substance and drug product development and manufacturing for New Biological Entities worldwide.

MEET THE TEAM

LMarek Photo_edited.jpg

Lubos Marek, PhD.

Lucia Ciglar final-.jpg

Lucia Ciglar, PhD.

Screenshot 2022-01-06 at 17.35.55.png

Javier Alfaro, PhD.

1538498285668-1.jpg

Stanislava Jurikova

1641685293954.jpg

Paul Dzacko

RADO 1.jpg

Radoslav Bielka

OUR FOCUS

focus1.png

 

AI/ML DRUG DISCOVERY

focus3.png

 

CONTRACT

DEVELOPMENT

focus2.png

 

CONTRACT

RESEARCH

focus4.png

 

CONTRACT

MANUFACTURING

OUR VALUES

CUSTOMER CENTRICITY

FLEXIBILITY

QUALITY

SPEED TO MARKET

SCIENTIFIC ADVISORY BOARD

Screenshot 2022-01-06 at 18.05_edited.jp

Prof. Sir David Philip Lane

Screenshot 2022-01-06 at 18.06.50.png

Prof. Ted Hupp

Screenshot 2022-01-06 at 18.07.43.png

Prof. Robin Fåhraeus

foto1-low_res-scale_edited.jpg

Prof. Philip J. Coates

Vojt_ek_edited.png

RNDr. BoÅ™ivoj VojtÄ›šek, DSc.

bottom of page